Nautilus Biotechnolgy
NAUT
NAUT
77 hedge funds and large institutions have $150M invested in Nautilus Biotechnolgy in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.54% more ownership
Funds ownership: 50.55% → 51.09% (+0.54%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
19% less capital invested
Capital invested by funds: $186M → $150M (-$36.2M)
Holders
77
Holding in Top 10
3
Calls
$7K
Puts
$1K
Top Buyers
| 1 | +$1.44M | |
| 2 | +$224K | |
| 3 | +$222K | |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$115K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
+$106K |
Top Sellers
| 1 | -$318K | |
| 2 | -$199K | |
| 3 | -$73.6K | |
| 4 |
AIG
American International Group
New York
|
-$73.1K |
| 5 |
JPMorgan Chase & Co
New York
|
-$61.7K |